Logo image of AED.BR

AEDIFICA (AED.BR) Stock Fundamental Analysis

EBR:AED - Euronext Brussels - BE0003851681 - REIT - Currency: EUR

65.075  -0.47 (-0.72%)

Fundamental Rating

4

AED gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 42 industry peers in the Diversified REITs industry. AED has a medium profitability rating, but doesn't score so well on its financial health evaluation. AED is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year AED was profitable.
AED had a positive operating cash flow in the past year.
AED had positive earnings in each of the past 5 years.
In the past 5 years AED always reported a positive cash flow from operatings.
AED.BR Yearly Net Income VS EBIT VS OCF VS FCFAED.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

AED has a better Return On Assets (3.17%) than 69.05% of its industry peers.
The Return On Equity of AED (5.62%) is better than 61.90% of its industry peers.
AED's Return On Invested Capital of 3.28% is in line compared to the rest of the industry. AED outperforms 50.00% of its industry peers.
AED had an Average Return On Invested Capital over the past 3 years of 3.33%. This is in line with the industry average of 3.66%.
Industry RankSector Rank
ROA 3.17%
ROE 5.62%
ROIC 3.28%
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
AED.BR Yearly ROA, ROE, ROICAED.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

The Profit Margin of AED (60.60%) is better than 71.43% of its industry peers.
In the last couple of years the Profit Margin of AED has declined.
AED has a better Operating Margin (76.93%) than 69.05% of its industry peers.
AED's Operating Margin has been stable in the last couple of years.
With an excellent Gross Margin value of 97.67%, AED belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
In the last couple of years the Gross Margin of AED has remained more or less at the same level.
Industry RankSector Rank
OM 76.93%
PM (TTM) 60.6%
GM 97.67%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
AED.BR Yearly Profit, Operating, Gross MarginsAED.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

1

2. Health

2.1 Basic Checks

AED has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, AED has about the same amount of shares outstanding.
AED has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, AED has a worse debt to assets ratio.
AED.BR Yearly Shares OutstandingAED.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AED.BR Yearly Total Debt VS Total AssetsAED.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.84, we must say that AED is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.84, AED is in line with its industry, outperforming 47.62% of the companies in the same industry.
A Debt/Equity ratio of 0.57 indicates that AED is somewhat dependend on debt financing.
The Debt to Equity ratio of AED (0.57) is better than 73.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Altman-Z 0.84
ROIC/WACC0.55
WACC6%
AED.BR Yearly LT Debt VS Equity VS FCFAED.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

AED has a Current Ratio of 0.32. This is a bad value and indicates that AED is not financially healthy enough and could expect problems in meeting its short term obligations.
AED has a worse Current ratio (0.32) than 69.05% of its industry peers.
A Quick Ratio of 0.32 indicates that AED may have some problems paying its short term obligations.
The Quick ratio of AED (0.32) is worse than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.32
Quick Ratio 0.32
AED.BR Yearly Current Assets VS Current LiabilitesAED.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 106.32% over the past year.
The Earnings Per Share has been decreasing by -7.20% on average over the past years.
AED shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.26%.
AED shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.35% yearly.
EPS 1Y (TTM)106.32%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%-16.97%
Revenue 1Y (TTM)9.26%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%13.14%

3.2 Future

AED is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.70% yearly.
AED is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.06% yearly.
EPS Next Y2.38%
EPS Next 2Y3.16%
EPS Next 3Y2.7%
EPS Next 5YN/A
Revenue Next Year5.99%
Revenue Next 2Y5.47%
Revenue Next 3Y5.06%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AED.BR Yearly Revenue VS EstimatesAED.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
AED.BR Yearly EPS VS EstimatesAED.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.11, AED is valued correctly.
The rest of the industry has a similar Price/Earnings ratio as AED.
Compared to an average S&P500 Price/Earnings ratio of 26.03, AED is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 12.42, the valuation of AED can be described as correct.
AED's Price/Forward Earnings ratio is in line with the industry average.
AED is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.11
Fwd PE 12.42
AED.BR Price Earnings VS Forward Price EarningsAED.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

AED's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 21.41
AED.BR Per share dataAED.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AED does not grow enough to justify the current Price/Earnings ratio.
AED has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)6.78
PEG (5Y)N/A
EPS Next 2Y3.16%
EPS Next 3Y2.7%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.35%, AED is a good candidate for dividend investing.
AED's Dividend Yield is slightly below the industry average, which is at 6.82.
Compared to an average S&P500 Dividend Yield of 2.36, AED pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.35%

5.2 History

The dividend of AED is nicely growing with an annual growth rate of 22.82%!
Dividend Growth(5Y)22.82%
Div Incr Years2
Div Non Decr Years2
AED.BR Yearly Dividends per shareAED.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

81.46% of the earnings are spent on dividend by AED. This is not a sustainable payout ratio.
The dividend of AED is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP81.46%
EPS Next 2Y3.16%
EPS Next 3Y2.7%
AED.BR Yearly Income VS Free CF VS DividendAED.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M
AED.BR Dividend Payout.AED.BR Dividend Payout, showing the Payout Ratio.AED.BR Dividend Payout.PayoutRetained Earnings

AEDIFICA

EBR:AED (5/22/2025, 9:11:10 AM)

65.075

-0.47 (-0.72%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)04-29 2025-04-29
Earnings (Next)07-30 2025-07-30
Inst Owners42.88%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap3.09B
Analysts79.05
Price Target73.22 (12.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.35%
Yearly Dividend3.51
Dividend Growth(5Y)22.82%
DP81.46%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.73%
PT rev (3m)3.92%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.71%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.24%
Valuation
Industry RankSector Rank
PE 16.11
Fwd PE 12.42
P/S 9.16
P/FCF N/A
P/OCF 12.45
P/B 0.85
P/tB 0.87
EV/EBITDA 21.41
EPS(TTM)4.04
EY6.21%
EPS(NY)5.24
Fwd EY8.05%
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)5.23
OCFY8.03%
SpS7.11
BVpS76.61
TBVpS74.75
PEG (NY)6.78
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.17%
ROE 5.62%
ROCE 4.38%
ROIC 3.28%
ROICexc 3.29%
ROICexgc 3.34%
OM 76.93%
PM (TTM) 60.6%
GM 97.67%
FCFM N/A
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
ROICexc(3y)3.34%
ROICexc(5y)3.28%
ROICexgc(3y)3.4%
ROICexgc(5y)3.38%
ROCE(3y)4.43%
ROCE(5y)4.34%
ROICexcg growth 3Y6.29%
ROICexcg growth 5Y0.95%
ROICexc growth 3Y7%
ROICexc growth 5Y0.65%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
F-Score8
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Debt/EBITDA 7.85
Cap/Depr 8867.91%
Cap/Sales 76.19%
Interest Coverage 250
Cash Conversion 94.51%
Profit Quality N/A
Current Ratio 0.32
Quick Ratio 0.32
Altman-Z 0.84
F-Score8
WACC6%
ROIC/WACC0.55
Cap/Depr(3y)11089%
Cap/Depr(5y)16628.2%
Cap/Sales(3y)126.51%
Cap/Sales(5y)150.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)106.32%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%-16.97%
EPS Next Y2.38%
EPS Next 2Y3.16%
EPS Next 3Y2.7%
EPS Next 5YN/A
Revenue 1Y (TTM)9.26%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%13.14%
Revenue Next Year5.99%
Revenue Next 2Y5.47%
Revenue Next 3Y5.06%
Revenue Next 5YN/A
EBIT growth 1Y8.46%
EBIT growth 3Y15.21%
EBIT growth 5Y24.47%
EBIT Next Year10.71%
EBIT Next 3Y6.49%
EBIT Next 5YN/A
FCF growth 1Y88.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.26%
OCF growth 3Y7.82%
OCF growth 5Y22.86%